Menopause and Hearing Loss: What 9 Studies Actually Found — and What to Do About It
Route the hearing concern before changing hormones
Find My HRT Path organizes the separate menopause-care decision. It does not diagnose hearing loss, replace audiology or ENT care, or tell you to start, stop, or change HRT.
Menopause and hearing loss are linked in research, but menopause has not been proven to independently cause hearing loss. Two U.S. analyses found no independent menopausal-status association after adjustment; a U.K. diagnosis study found adjusted associations. Hearing can change across midlife. HRT is not a hearing treatment. A sudden drop — especially in one ear — needs same-day medical care.
That's the honest headline. Now here's the part almost nobody explains: the studies on this question look like they contradict each other, and much of the conflict comes from what they measured. Once you see the split between hearing tests, self-reports, diagnosis codes, and repeated testing over time, the pile of headlines starts to make sense — and so does what you should actually do next.
| Your question | The short answer |
|---|---|
| Does menopause cause hearing loss? | Not proven as a cause; adjusted studies conflict on whether menopausal status is associated |
| Is the change I'm noticing real? | It can be. Repeated hearing tests show measurable decline in some women across these years |
| Does HRT treat or prevent it? | No. No FDA-approved hormone therapy is indicated for hearing loss, and human studies show no proven hearing benefit |
| Should I stop my HRT over this? | No. Do not change a prescribed medication because of a webpage; raise the concern with your prescriber |
| What's the best next step? | A diagnostic hearing evaluation — same day if the change was sudden, routine if it has been gradual |
This page is for you if you're roughly 40 to 60, conversations have gotten harder — especially in noisy rooms — and you want to know what's actually established before you decide anything.
This page is not for you if your hearing dropped suddenly, especially in one ear. Stop reading and get seen today. See the red box below. If your main problem is ringing rather than muffling, you want menopause and tinnitus instead. If it's spinning and imbalance, go to menopause and dizziness.
Get care today, not next week, if any of this is true
A sudden hearing drop is a medical emergency, not a menopause symptom to watch at home. Same-day assessment matters because sudden sensorineural hearing loss can feel like wax or fullness, and treatment is time-sensitive. Neurological symptoms, severe vertigo, or head injury raise the urgency further.
- Your hearing dropped suddenly in one or both ears — over hours or a few days
- New hearing loss plus facial weakness, trouble speaking, a severe headache, or new numbness
- New hearing loss plus sudden severe vertigo
- New hearing loss after a head injury
Why the rush? Sudden sensorineural hearing loss is a rapid drop caused by a problem in the inner ear or hearing nerve. A commonly used diagnostic definition is a loss of at least 30 decibels across three neighboring frequencies within 72 hours, but subtler sudden changes can still qualify and still need urgent assessment.
The treatment window was easy to misstate, so here is the current guideline language precisely: hearing should be confirmed with audiometry as soon as possible and within 14 days; corticosteroids may be offered as initial treatment within two weeks; and intratympanic steroid salvage is recommended for incomplete recovery two to six weeks after onset. That does not mean you should wait two weeks. The safest reader action is same-day assessment because delay can reduce treatment effectiveness. (AAO-HNS guideline; NIDCD)
Do not wait to see whether it's menopause.
*What is not automatically an emergency:*
- Gradual difficulty in both ears, especially in noisy places
- Long-standing trouble that has not changed
- A day or two of muffling with an obvious cold or blocked nose
- Ringing without a sudden hearing change
Those patterns can still need care. New one-sided tinnitus, persistent fullness, fluctuating hearing, pain, drainage, or a clear difference between ears deserves prompt assessment even when the change was not sudden. This is not a complete list of emergency symptoms. When you're unsure, get checked.
Can menopause cause hearing loss?
Menopause has not been established as an independent cause of hearing loss. Two U.S. studies found no significant independent association after adjustment, while a large U.K. diagnosis-code study found adjusted associations. Repeated testing also shows hearing can decline across these years. The evidence is mixed on association and does not prove menopause caused an individual's change.
Here's the thing that makes this question so slippery: menopause and age-related hearing loss occupy the same stretch of the calendar.
The average age of menopause in the United States is 52, and the usual range is 45 to 58. Age-related hearing change also accumulates over time, commonly affecting higher frequencies first. That makes the two look connected before a study has done anything to separate them. (Office on Women's Health)
The research question is whether menopause is doing it, or simply happening nearby.
Two U.S. studies took that question seriously.
The Nurses' Health Study II followed 80,972 American women for 22 years. When researchers compared postmenopausal with premenopausal women and adjusted finely for age and other factors, natural menopause carried a relative risk of 1.00 (95% CI 0.94–1.05). Surgical menopause was 0.95 (0.89–1.02). A relative risk of 1.00 means the groups had the same measured risk in that analysis. (Curhan et al., 2017)
Then in April 2026, a USC-led team published a national analysis using actual hearing tests rather than asking women how their hearing seemed. After adjustment, postmenopausal status was associated with a +0.92 dB difference (95% CI −1.02 to 2.86), which was not statistically significant.
Before adjustment, the raw difference was 5.78 dB. After age and other factors entered the model, it fell to 0.92 dB. That is strong evidence that age and related characteristics explain much of the crude difference in that dataset. It is not proof that hormones play no role in any woman. (Hsu et al., 2026)
What this does not mean: it does not mean you're imagining things. The studies that followed the same women through the menopausal transition did record change. They simply cannot, by themselves, prove that menopause rather than aging caused it.
When is a hearing change an emergency?
A sudden drop over hours to days needs same-day medical care, particularly when one ear is affected. Gradual, roughly even difficulty in noisy rooms is usually not an emergency, but it still deserves a baseline evaluation. The three clues that matter most are speed, sidedness, and whether neurological symptoms came with it.
Speed matters most. Hearing that fades over months behaves differently from hearing that drops over a weekend.
Sidedness matters next. Age-related change is commonly bilateral, although the ears are not always identical. A clear new difference between ears is not something to write off as menopause, and it can point to a specific cause that needs evaluation.
Anything neurological — face drooping, slurred speech, new weakness or numbness, a thunderclap headache, or severe sudden imbalance — is an emergency call, full stop. Do not use any website, including this one, to talk yourself out of that.
One more thing worth saying plainly. If your ear feels blocked and you assume it's wax, allergies, or “just hormones,” you may be right. But an ear exam can only look for conductive causes such as wax or fluid; it cannot rule out sensorineural loss by itself. Air- and bone-conduction audiometry helps separate conductive from sensorineural patterns. (NIDCD)
Not sure whether yours can wait?
Use the pattern table on this page: sudden or neurological goes to same-day care; one-sided, fluctuating, painful, draining, or vertigo-associated goes to a physician or ENT promptly; gradual, both-sided difficulty generally starts with a diagnostic audiology appointment. Do not start, stop, or change HRT while you sort out an ear symptom. The hearing question and the hormone question are separate decisions.
What is the right next step for me?
The hearing decision comes first, and the HRT decision remains separate. Urgent ear patterns need medical care; gradual patterns need testing. Once the ear question is routed safely, The HRT Index's Find My HRT Path tool can help with the separate question of which menopause-care model fits your symptoms, risks, preferences, insurance, and state.
The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.
The live tool states that no email or account is required, nothing is sold or stored, and health answers remain on the page. See the Consumer Health Data Privacy Policy before entering sensitive information.
The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.
What are the 7 signs women actually notice around menopause?
Hearing change in midlife rarely starts with silence. It starts with effort. The first complaint is often clarity rather than volume: you can tell someone is speaking, but separating the words becomes hard when noise is behind them. Six other patterns recur, and each one changes what should be tested or how quickly it should be checked.
Here's what women describe, and what each sign can mean.
1. Restaurants have become impossible. This is the classic first sign, and it's the one most often dismissed. Background noise removes the redundancy your brain uses to fill in gaps. Even a small high-frequency change can show up there before it causes obvious trouble in quiet.
2. You can hear that someone's talking, but not what they said. Consonants such as s, f, th, and sh carry much of the detail in speech and sit higher in frequency than many vowels. You get the shape of the sentence and lose the edges.
3. Women's and children's voices are harder than men's. Higher-pitched voices can sit closer to the frequencies where age- and noise-related loss often begins. That pattern is useful information for an audiologist, not a personality trait.
4. You're exhausted after a day of meetings. Listening fatigue is real. When the signal is degraded, the brain has to do more reconstruction. Some people notice the effort before they identify it as hearing difficulty.
5. Someone else has mentioned the TV volume. You may not notice a slow drift. The people around you often do. It's an unglamorous but genuinely useful data point.
6. One ear feels blocked or “full,” and nothing comes out. This is different from ordinary both-sided difficulty. Wax, fluid, pressure problems, inner-ear conditions, and sudden sensorineural loss can all feel “blocked.” One-sided or sudden fullness deserves assessment rather than waiting.
7. You've started avoiding things. Skipping the group dinner. Choosing the quiet table. Emailing instead of calling. This is the sign with the biggest life cost, and it is often the one women mention last.
The FDA's OTC hearing-aid guidance uses much of the same symptom language — trouble in noise, trouble in groups, phone difficulty, listening fatigue, and a TV volume other people find too loud. Its medical red flags include sudden, rapidly worsening, fluctuating, or one-sided loss; vertigo; pain or drainage; and one-sided tinnitus. (FDA OTC hearing-aid guidance)
| What you notice | What it may reflect | Test or assessment that helps | Urgency |
|---|---|---|---|
| Can't follow speech in noise | High-frequency loss or speech-in-noise difficulty | Pure-tone audiogram plus speech-in-noise testing | Routine, but get it measured |
| Muffled in both ears, gradual | Age/noise-related change, wax, or another bilateral cause | Audiogram + ear exam | Routine |
| One ear clearly worse | Asymmetric loss that needs a cause | Audiogram + medical evaluation; ENT if indicated | Prompt |
| Sudden drop | Possible sudden sensorineural hearing loss | Same-day medical assessment + audiometry | Same day |
| Blocked/full feeling | Wax, middle-ear pressure/fluid, or inner-ear disease | Otoscopy + tympanometry + audiometry as indicated | Prompt if sudden, one-sided, or persistent |
| Listening fatigue, “normal” tone test | Speech-in-noise difficulty a basic threshold test can miss | Speech-in-noise testing specifically | Routine — ask for it by name |
| Ringing with hearing change | Tinnitus alongside hearing loss | Audiogram; see menopause and tinnitus | Prompt if sudden, one-sided, or pulsatile |
What women are actually trying to figure out “Is this menopause, aging, wax, or something serious?” · “My beep test was normal but conversations are exhausting.” · “Why is it only one ear?” · “Some articles say HRT causes it, others say it helps.” · “Should I stop my HRT?” · “Nobody warned me this could happen.” These are reader questions, not testimonials. They're here because they are normal questions — not because they prove anything medically.
What do 9 studies on menopause and hearing loss actually show?
Nine selected studies make up the evidence matrix below, and they do not all point in one direction. They used hearing tests, self-reports, diagnosis codes, snapshots, and repeated measurements. Put the methods beside the findings and the conflict becomes useful instead of frightening.
This is our Menopause–Hearing Evidence Matrix, verified August 2026. It is a curated evidence set, not a claim that only nine studies exist. Every row shows what the study found and what it cannot establish.
| Study | Design and population | How hearing was measured | What it found | What it cannot tell you | What it means for you |
|---|---|---|---|---|---|
| Hsu, Gu, Nguyen & Choi 2026, Annals of Otology, Rhinology & Laryngology | Cross-sectional NHANES analysis; 1,778 US women ages 40–69 | Better-ear pure-tone average at 0.5, 1, 2, and 4 kHz | Postmenopausal status: +0.92 dB (95% CI −1.02 to 2.86), not significant. Late menopause versus before 45: −4.60 dB. Longest versus shortest reproductive-lifespan quartile: −4.86 dB. HRT: +0.45 dB, not significant | Cause and effect; HRT type, dose, route, and duration | The strongest current US audiometry evidence against treating menopausal status itself as the cause |
| Fu et al. 2025, Maturitas | Prospective UK Biobank analysis; 214,327 women ages 40–69; mean follow-up 13.42 years; 5,106 diagnoses | Hearing-loss diagnosis codes in health records | Premature natural menopause under 40: HR 1.27. Four or more births: HR 1.29. Short and long reproductive lifespans were associated with higher risk. MHT use was associated with higher risk among women with typical-age natural menopause, but not significantly among premature- or late-menopause groups. Cardiovascular disease mediated 46.07% of the parity association and 19.61% of the premature-menopause association | That menopause caused the diagnosis; measured hearing thresholds; how an individual woman's risk changes | Reproductive history and cardiovascular health may carry useful context, but diagnosis-code associations are not a treatment instruction |
| Jang et al. 2025, Maturitas | Longitudinal cohort; 4,448 Korean women ages 42–52; modeled from 11 years before to 9 years after the final menstrual period | Repeated audiometry | 71.7% had stable hearing until the final period and then declined; 28.3% began poorer and declined more steeply. The poorer trajectory had more overweight/obesity and hyperglycemia at baseline | Whether the final menstrual period caused the change rather than marking a stage of aging; generalizability beyond this cohort | Strong evidence on trajectories and timing, not proof that replacing estrogen reverses them |
| Curhan et al. 2017, Menopause | Prospective Nurses' Health Study II; 80,972 US women; 22 years; 18,558 cases | Self-reported hearing loss | Menopausal status was not associated overall: natural RR 1.00, surgical 0.95. Later natural menopause: 1.10. Oral HRT for 10+ years: 1.21 | Changes in measured thresholds; direct causation; broad generalizability from a cohort that was more than 94% White | The source of the longer-duration oral-HRT signal — and a reason to discuss, not abruptly alter, treatment |
| Svedbrant et al. 2015, Acta Otolaryngologica | Ten-year follow-up of a Swedish menopausal cohort | Repeated audiometry | The authors reported an unexpectedly rapid decline that remained at ten years | Independence from aging; the cohort did not provide an age-matched control that could isolate menopause | Long-term confirmation that change occurred in this cohort, not proof of the mechanism |
| Hederstierna et al. 2010, Hearing Research | Longitudinal; 104 healthy Swedish women, mean age about 51; tested twice about 7.5 years apart | Audiometry | The authors concluded that menopause appeared to trigger a relatively rapid age-related decline, first in the left ear | Whether menopause rather than aging caused it; small sample and attrition | Historically important, but too limited to carry the headline conclusion alone |
| Guimaraes et al. 2006, PNAS | Retrospective comparison; 124 postmenopausal women ages 60–86 | Pure tones, otoacoustic emissions, and hearing in noise | The estrogen-plus-progestin group performed worse; estrogen-alone resembled the no-HRT group more closely | Causation; effects of current formulations and prescribing; unmeasured differences between groups | The source of the “progestin is the problem” story — a story the larger prospective data did not confirm |
| Kilicdag et al. 2004, American Journal of Obstetrics & Gynecology | Prospective, nonrandomized; 109 postmenopausal women | Low- and high-frequency audiometry | Estrogen therapy appeared to slow some decline; the combined-therapy group did not show the same pattern | A definitive treatment effect; participants selected treatment rather than being randomized | One root of the “estrogen protects hearing” theory, not evidence to prescribe it for hearing |
| Kim et al. 2002, Obstetrics & Gynecology | Cross-sectional; 1,830 postmenopausal women | Audiometry, serum estradiol, and bone density | Lower serum estradiol was independently associated with poorer hearing sensitivity | That raising estradiol improves hearing; direction of cause and effect | Biological plausibility, not an instruction to use estrogen for the ears |
⚠️ One set of numbers needs a warning label, but not erasure. Fu's study reported adjusted hazard ratios of roughly 2.5 for natural menopause and 2.7 for surgical menopause compared with premenopause. Those are real results from its model. They are also diagnosis-code associations in an observational UK Biobank cohort, not proof that menopause nearly triples hearing loss or a personal risk estimate you can apply to yourself.
That result sits beside two U.S. analyses in which menopausal status was not independently associated after adjustment. The outcomes and designs differ enough that one study cannot simply cancel the other. The correct conclusion is that the epidemiology is mixed — not that the largest-looking ratio automatically wins, and not that it can be dismissed as a raw age comparison.
We're telling you this about a study we're citing. That's the point of the limitations column.
Why do the studies disagree?
They disagree partly because they measured different outcomes — and partly because the evidence is genuinely unsettled. Repeated audiometry can show when hearing changes. Self-reports capture noticed difficulty. Diagnosis codes capture who reached clinical care. Cross-sectional hearing tests compare groups at one point. None answers every part of the question.
Look at the matrix again with that lens.
Group one — follow the same women over time: Hederstierna, Svedbrant, and Jang all recorded decline. These designs are good at showing trajectories. They are weaker at separating a menopause effect from aging, cohort effects, and other changes happening over the same years.
Group two — compare menopausal groups while accounting for age and other factors: Curhan and Hsu found that menopausal status itself was not independently associated. Curhan used self-report; Hsu used audiometry. Neither proves that hormone changes are irrelevant to every woman.
Group three — follow diagnoses across reproductive histories: Fu found associations with premature menopause, parity, reproductive lifespan, and menopausal status. That design reaches enormous scale, but a diagnosis code is not the same endpoint as an audiogram.
So here's the honest synthesis:
Your hearing may be changing across the menopausal years. The evidence has not established that menopause itself, rather than aging and connected health factors, is the independent cause.
That sounds like a technicality. It isn't. It changes what you do.
If you believe menopause is the cause, the logical move is to fix the hormones and expect your hearing to follow. That's the reasoning most of the internet nudges you toward, and it is the reasoning most likely to waste time — because the hormone evidence does not support HRT as a hearing treatment.
If you understand that the cause still needs finding, the plan becomes different: measure the hearing, look for reversible and modifiable contributors, and treat menopause symptoms on their own merits.
Same uncertainty. A much better plan.
Does later menopause protect your hearing?
The two large U.S. studies point in opposite directions, and neither gives you a clinical rule. The Nurses' Health Study found slightly higher self-reported risk with later natural menopause. The 2026 audiometry study found better measured thresholds with later menopause and a longer reproductive lifespan. The disagreement is real.
| Curhan 2017 | Hsu et al. 2026 | |
|---|---|---|
| Outcome | Self-reported hearing loss | Measured better-ear hearing thresholds |
| Later menopause | Higher reported risk for age 50+ versus under 50: RR 1.10 (1.03–1.17) | Better measured hearing for age 55+ versus under 45: −4.60 dB (−8.42 to −0.79) |
| Among women who never used HRT | Menopause at 55+: RR 1.29 (1.11–1.50) | — |
| Longer reproductive lifespan | Not examined in the same way | Highest versus lowest quartile: −4.86 dB (−8.28 to −1.44) |
Why would the same variable point two ways?
One plausible explanation is the outcome. Self-report captures whether you noticed and reported difficulty. Audiometry captures thresholds at selected frequencies in a quiet setting. Those are not interchangeable. Women who reach menopause later may also differ in health, exposure, genetics, and care-seeking in ways no model can fully remove.
Curhan's team called its later-menopause finding unexpected and said the mechanism was unclear. Hsu's team said the clinical relevance of modest threshold differences needs further study.
The practical answer is simple: age at menopause does not tell you whether your current hearing problem is hormonal, reversible, or treatable. It belongs in your history, not in a self-treatment formula.
We could have picked whichever study made a cleaner story. We'd rather you saw both.
What does estrogen actually do in the ear?
Estrogen signaling exists in the inner ear, so a hormone–hearing connection is biologically plausible. Human tissue research has found estrogen receptors in cochlear structures, and animal experiments show that changing estrogen signaling can change hearing. The experiments also point in opposite directions, which is exactly why mechanism cannot substitute for human treatment evidence.
In adult human inner-ear tissue, researchers identified estrogen receptor alpha in spiral ganglion neurons and estrogen receptor beta in the stria vascularis. The stria vascularis helps maintain the ionic environment the cochlea needs to turn sound into nerve signals. (Stenberg et al., 2001)
Animal work broadens that map and makes the biology look compelling. Mice lacking estrogen receptor beta developed severe age-related hearing problems and inner-ear pathology. (Simonoska et al., 2009)
Then the biology refuses to stay tidy.
In a mouse model of adult-onset hearing loss, estrogen alone and estrogen-plus-progestin worsened aspects of cochlear degeneration, while removing ovarian hormone exposure reduced some damage. (Price et al., 2009)
That is the counterweight most articles leave out. A receptor proves that a tissue can respond to a hormone. It does not tell you whether adding that hormone helps, harms, or does nothing in a woman with gradual hearing difficulty.
The mechanism is plausible. The treatment conclusion is not established.
Does HRT help hearing loss — or make it worse?
HRT is not a treatment for hearing loss, and no FDA-approved menopausal hormone therapy is indicated for it. Curhan linked longer oral use with higher self-reported risk; Fu found higher diagnosis risk in one MHT subgroup; Hsu found no significant association. None showed hearing benefit or supports changing HRT for hearing alone. (FDA; Curhan 2017; Fu 2025; Hsu 2026)
Our one damaging admission
We'd rather you heard this from us than found it in a study abstract at midnight.
There is no version of the human evidence in which hormone therapy is an established treatment for your hearing. Curhan's large cohort pointed slightly the wrong way for estrogen alone as well as combined therapy, Fu found higher diagnosis risk in one MHT subgroup, and Hsu found no significant association. If protecting your hearing is your reason for considering HRT, that's not a good reason. Close this page and book the hearing test instead.
And here's why that's genuinely good news for you.
Because HRT is not the hearing lever, you do not have to solve the hormone question before you do anything. The useful actions are available now:
- A diagnostic hearing evaluation
- A medication review
- A check of whether bone-health screening is due for your age and risk
- Blood-pressure and blood-sugar follow-up when clinically indicated
- Protection from damaging noise
- Amplification or other rehabilitation if testing shows a need
None of that waits on a hormone decision.
And if you're already taking HRT for hot flashes, sleep disruption, or another menopause indication — this page is not a reason to stop. Symptoms may return after discontinuation, and stopping offers no proven hearing benefit. Bring the hearing concern to your prescriber and evaluate your ears separately.
If the broader benefit-and-risk picture of HRT is what's actually worrying you, we've laid out what the major evidence can and cannot establish without the scare headlines. See what the HRT evidence actually supports →
Does the type or route of HRT change anything?
No route or formulation has been proven to protect hearing. The claim that estrogen helps while progestin harms comes largely from a small 2006 comparison, but the 80,972-woman prospective cohort did not reproduce that pattern. Its transdermal results were described as similar to oral results, although patch use was less common.
These numbers come from Tables 4 and 5 of the full Curhan paper.
By duration — current oral HRT compared with never using it:
| Duration of oral HRT | Relative risk (95% CI) | What the study found |
|---|---|---|
| Under 1 year | 1.09 (0.98–1.21) | Not statistically significant |
| 1 to under 2 years | 1.10 (1.00–1.21) | Confidence interval touched 1.00 |
| 2 to under 5 years | 1.08 (1.00–1.16) | Confidence interval touched 1.00 |
| 5 to under 10 years | 1.15 (1.06–1.24) | Statistically significant association |
| 10+ years | 1.21 (1.07–1.37) | Statistically significant association |
The shorter-duration estimates were not clearly significant. That is a meaningful detail the headlines dropped.
By type, at five or more years:
| Type | Relative risk (95% CI) |
|---|---|
| Oral estrogen alone | 1.18 (1.07–1.30) |
| Oral estrogen plus progestogen | 1.14 (1.04–1.26) |
| Progestogen only, ever used | 1.15 (0.98–1.35) — not statistically significant |
Read those first two rows again. Estrogen alone was not lower than combined therapy in this dataset. The neat “progestin is the villain” story does not survive the larger prospective comparison.
And on patches: transdermal use was less common, but the paper states that its associations were similar to oral use. That does not prove patches carry hearing risk. It does mean “switch to a patch for your hearing” is not supported by this study.
Three things this section is not saying
It is not saying stop or switch your HRT. Do not change a prescribed dose or route because of a webpage.
It is not saying remove endometrial protection. For a woman with an intact uterus using systemic estrogen, adequate progestogen is generally recommended to reduce endometrial risk. Recommended low-dose vaginal estrogen for genitourinary symptoms is a separate category and generally does not require a progestogen. (The Menopause Society 2022 position statement)
It is not saying the hearing numbers are settled. They are observational associations with modest effect sizes, self-reported hearing, and a cohort that was more than 94% White. The paper also disclosed that Sharon Curhan and Gary Curhan were consultants to Decibel Therapeutics. That disclosure does not invalidate the study; it belongs beside it.
What else could be causing this?
Several causes of midlife hearing change are more findable — and sometimes more fixable — than hormones. Wax, middle-ear problems, noise damage, medication effects, and inner-ear conditions can produce overlapping symptoms. The pattern narrows the possibilities, but an ear exam and hearing test do the separating.
| Possible cause | What it can feel like | How it is evaluated | Can it improve? |
|---|---|---|---|
| Earwax blockage | Fullness, muffling, sometimes one ear | Otoscopy — looking into the ear canal | Often, after safe removal |
| Middle-ear fluid or Eustachian tube dysfunction | Blocked or “underwater,” popping, often after a cold or pressure change | Ear exam and tympanometry | Often |
| Noise-induced hearing loss | Gradual difficulty, usually high-frequency, sometimes with tinnitus | Exposure history and audiogram | Usually not reversed; future exposure can be reduced |
| Medication-related ototoxicity | Hearing change, tinnitus, or imbalance; timing depends on the drug and dose | Dated medication review and hearing testing | Depends on the medicine and injury; changes belong with the prescriber |
| Otosclerosis | Gradual loss that often starts in one ear; low pitches may be difficult | Audiogram and specialist assessment | Treatable in some cases with devices or surgery |
| Ménière's disease | Episodes of vertigo with fluctuating hearing, tinnitus, or fullness | ENT assessment and documented hearing testing | Symptoms can be managed; course varies |
| Vestibular schwannoma (acoustic neuroma) | Often progressive one-sided loss or one-sided tinnitus | Audiogram, medical assessment, and imaging when indicated | Requires specialist management |
| Sudden sensorineural hearing loss | Rapid drop, often one ear, sometimes with fullness or tinnitus | Same-day medical assessment and audiometry | Recovery varies; early treatment matters |
The table is a routing aid, not a self-diagnosis. Otosclerosis, Ménière's disease, and vestibular schwannoma are distinct conditions, and the same word — fullness, muffling, ringing — can appear in more than one of them. (NIDCD hearing conditions)
On medication effects, one caution matters more than any drug list. Do not stop a prescription because you saw its name beside the word ototoxic. If the hearing change followed a new medicine, a dose change, or a course of treatment, bring the exact product, dose, start date, and symptom date to the prescriber or pharmacist. The timeline is the useful evidence.
Notice what the table keeps asking for: an exam, a test, or both. That's the argument for measuring instead of guessing.
What else raises hearing-loss risk in midlife?
Noise exposure, medication history, cardiovascular and metabolic health, and low bone density are more actionable than menopausal status alone. That does not make each one the cause of your hearing change. It means they can be documented, reviewed, and addressed without waiting for the hormone research to settle.
The cardiovascular finding is the one most likely to be overread.
In the UK Biobank study of 214,327 women, a statistical mediation model estimated that cardiovascular disease accounted for 46.07% of the association between four or more childbirths and hearing-loss diagnosis, and 19.61% of the association between premature menopause and hearing-loss diagnosis. (Fu et al., 2025)
That does not prove the signal “travelled through the blood vessels,” and it does not prove that treating cardiovascular disease will prevent hearing loss. Mediation analysis estimates how associations fit together under model assumptions; it is not a treatment experiment.
The Korean repeated-audiometry study points in a compatible but still observational direction: women in the poorer hearing trajectory were more likely to have overweight or obesity and hyperglycemia. (Jang et al., 2025)
Two large cohorts, two different designs, a reason to take general health seriously — not permission to turn association into a cure.
| Factor | What is established here | Modifiable? | What it changes for you |
|---|---|---|---|
| Noise exposure | Excessive noise can damage inner-ear structures and cause permanent hearing loss | Future exposure, yes | Protect the hearing you still have |
| Cardiovascular and metabolic health | Associated with hearing outcomes in large cohorts; causality and hearing benefit from risk-factor treatment are not settled | Often | Manage blood pressure, glucose, and cardiovascular risk for established health reasons |
| Medications | Some medicines can affect hearing or balance | Sometimes, through the prescriber | Bring a dated medication timeline; do not stop on your own |
| Bone density | Low bone density or osteoporosis was associated with higher hearing-loss risk in two long-running cohorts | Bone and fracture risk can be assessed and treated | Check whether you meet current osteoporosis-screening criteria |
The useful move is not to decide which row “caused” it before the appointment. The useful move is to arrive with enough evidence that the clinician does not have to start from fog.
Is low bone density linked to hearing loss? The bone connection nobody mentions
Low bone density and osteoporosis were associated with up to about a 40% higher risk of moderate-or-worse hearing loss in two cohorts totaling 143,899 women. The study did not prove that bone loss caused hearing loss, and bisphosphonate use did not change the association. It is a real signal with a hard limit.
The analysis combined the Nurses' Health Study — 60,821 women followed from 1982 to 2016 — and Nurses' Health Study II — 83,078 women followed from 1995 to 2017. A history of vertebral fracture was also associated with higher risk; hip fracture was not. The outcome was self-reported hearing loss, not measured thresholds. (Curhan et al., 2021)
This is one of the clearest measurable associations in this evidence set, and it has nothing to do with using HRT as an ear treatment.
Why might bone and hearing travel together? The inner ear is encased in bone, and bone metabolism, vascular health, age, and other systemic factors may overlap. The study cannot tell us which mechanism explains the association.
The bisphosphonate result is the damaging detail inside the interesting finding: women who used those medications did not have a different hearing-loss risk from women who did not. That argues against the easy story that treating bone density automatically protects hearing.
Here is the part that changes an appointment.
Current USPSTF guidance recommends osteoporosis screening for all women 65 and older and for postmenopausal women younger than 65 who are at increased fracture risk after clinical risk assessment. It does not recommend a bone-density scan for every woman simply because she has reached menopause or noticed a hearing change. (USPSTF osteoporosis screening recommendation, 2025)
So do not ask for a bone test “for your ears.” Ask whether you meet bone-screening criteria for your age and risk history. If that part of midlife care has been skipped, close the gap for the reason the test is designed to address — fracture prevention — and treat the hearing question separately.
I can hear the beeps but I still can't follow speech. What's going on?
A pure-tone test can look normal or near-normal while real conversation still feels exhausting. Beeps in a quiet booth measure the softest tones you detect at individual frequencies. They do not fully reproduce competing voices, reverberation, visual distraction, attention, or the work of separating speech from noise.
This is the single most invalidating experience in this whole topic. You do the test, someone says the numbers are “normal,” and you go home still unable to hear your friend across a restaurant table.
The 2026 U.S. study on this page used a better-ear pure-tone average at 0.5, 1, 2, and 4 kHz. That is a useful standard measure. It is also an average of four frequencies, in the better ear, in controlled conditions. (Hsu et al., 2026)
A small high-frequency change can be diluted inside an average. More importantly, understanding speech in noise depends on more than whether you can detect a tone. That is why the complaint and the test result can both be honest.
What to do about it: ask whether speech-in-noise testing is appropriate for your complaint. Ask to see each ear's thresholds across the full frequencies tested, not just the average. Ask for a copy of the audiogram and speech results so future testing has a documented comparison point.
Take this sentence into the appointment:
“My main difficulty is understanding speech in background noise. Can we test that directly, even if my pure-tone thresholds are in the normal range?”
That is more accurate than telling the clinician what your diagnosis must be. It names the failure point and asks for the test that resembles it.
Is hearing loss really linked to dementia?
Yes, hearing loss is treated as a potentially modifiable dementia risk factor — but that is not the same as saying it causes dementia or that a hearing aid guarantees prevention. The 2024 Lancet Commission assigned hearing loss a 7% weighted population-attributable fraction. The major U.S. randomized trial was negative in its overall primary analysis.
Let's do this carefully, because this is the fear that brings a lot of women to this page at 1 a.m.
What the Lancet Commission estimated. Its life-course model included 14 potentially modifiable factors with a combined weighted population-attributable fraction of 45.3%. Hearing loss was classified as a midlife factor with an estimated relative risk of 1.4 (95% CI 1.0–1.9) and a 7% weighted fraction. The authors also said some associations might be only partly causal. A population-attributable fraction is a model of population-level potential under assumptions — not a forecast for one woman. (2024 Lancet Commission)
What the ACHIEVE trial found. The trial randomized 977 adults ages 70 to 84 with untreated hearing loss to a hearing intervention or health-education control and followed them for three years. In the full study population, the intervention did not significantly slow cognitive decline. (Lin et al., 2023)
The 48% result came from a prespecified subgroup: 238 participants already enrolled in a cardiovascular-health cohort who were older on average and had more cognitive-risk factors. In the 739 healthier community volunteers, the intervention did not reduce cognitive decline over three years.
A later secondary analysis regrouped people by predicted cognitive-decline risk and found greater benefit in the highest-risk quartile. That refines who may benefit; it does not rewrite the original trial into an overall positive result. (Pike et al., 2025)
And the detail that matters most for this page: ACHIEVE enrolled adults 70 to 84, not women in their 40s or 50s navigating menopause.
So what is fair to conclude?
Hearing loss is associated with dementia risk strongly enough to justify serious research and public-health attention. Treating hearing loss may help cognition in some older, higher-risk adults, but prevention is not guaranteed and the evidence cannot be copied onto a 52-year-old. Hearing care still has immediate value: clearer communication, less daily effort, better access to the people around you.
Being able to hear your people is enough reason to get the test. You do not need a dementia scare to earn it.
Is menopause-related hearing loss reversible?
Reversibility depends on the type and cause, not on whether the change happened near menopause. Conductive loss from wax, fluid, or some middle-ear problems can often improve when the blockage or condition is treated. Gradual sensorineural loss from inner-ear or nerve damage is usually permanent. Sudden sensorineural loss is the time-critical exception.
The honest answer nobody wants to give: there is no proven treatment that reverses gradual age-related sensorineural hearing loss. Not HRT. Not a supplement. Not a food plan.
What we do have is real:
- Treatment of reversible causes such as wax or selected middle-ear problems
- Prevention of additional noise injury with safer exposure and hearing protection
- Prescriber-led medication review when the timing raises concern
- Amplification and assistive technology when testing shows they fit
- Communication strategies that reduce the daily work even when thresholds do not change
A hearing aid does not return the ear to normal, and not every person with difficulty needs one. It can make speech and environmental sound more usable when properly matched to the loss.
For sudden sensorineural hearing loss, partial or full recovery is possible, but the outcome varies and treatment is time-sensitive. That is the entire reason the red box sits before the explanation.
Some causes may improve. Most gradual sensorineural loss will not reverse. All of it is worth identifying, because “permanent” and “nothing can help” are not the same sentence.
What hearing test should I get, and how do I read it?
Ask for a diagnostic audiologic evaluation, not only a quick screening. The exact battery should match your symptoms, but it commonly includes an ear-canal check, pure-tone and speech testing, and sometimes tympanometry. When speech in noise is the complaint, ask whether speech-in-noise testing can be added. (American Academy of Audiology adult assessment guidance)
Here is what each part does.
Otoscopy — someone looks into the ear canal and at the eardrum. It can find wax and visible outer- or middle-ear clues. It cannot rule out sudden sensorineural hearing loss by itself.
Tympanometry — measures how the eardrum and middle ear respond to a pressure change. It can help identify fluid or middle-ear pressure problems. It is not needed in every case, so ask what your symptoms call for.
Pure-tone audiometry — the beeps. It measures the softest sound you detect at different pitches in each ear and produces the audiogram.
Speech testing — measures how well you detect or repeat speech under controlled conditions.
Speech-in-noise testing — directly tests the complaint many women bring in: hearing a voice when competing sound is present. It may not be part of every routine battery, so name the problem and ask whether the test is available.
Reading the audiogram, in plain terms: the horizontal axis is frequency, from lower pitch on the left to higher pitch on the right. The vertical axis is the hearing level needed for detection; marks farther down generally mean more sound was required. Right- and left-ear results are plotted separately.
A downward slope toward the higher frequencies is common in age- or noise-related loss, but the shape does not diagnose the cause by itself. The two things worth asking about are:
- Do the ears differ enough to need medical follow-up?
- Do the speech results match the pure-tone thresholds and my real complaint?
Ask for a copy of the audiogram and all speech scores. It gives future testing a documented comparison point instead of forcing everyone to rely on memory.
Ready to get the baseline?
A diagnostic hearing test commits you to nothing. No device. No prescription. No agreement to buy from the clinic. Use this booking sentence: “I have gradual difficulty understanding speech in background noise. I want a diagnostic audiologic evaluation, and I want to ask whether speech-in-noise testing is available.” If the change was sudden, one-sided, painful, draining, or paired with vertigo or neurological symptoms, do not use the routine script. Seek medical assessment first.
Need a directory rather than another article? Search the American Academy of Audiology's Find an Audiologist directory by location and specialty. Medicare beneficiaries can also use Medicare Care Compare and then confirm network status, referral rules, and whether the clinic offers the tests you need.
What does a hearing test cost, and what does insurance cover in 2026?
There is no honest single U.S. cash price for a hearing test. Your bill depends on the tests performed, the facility, network status, referral rules, and whether the visit is diagnostic or for hearing-aid fitting. Medicare's diagnostic coverage is specific; commercial and Medicare Advantage benefits must be checked plan by plan.
This trips up almost everyone, so let's be blunt about it. A diagnostic evaluation and a hearing-aid fitting may happen in the same clinic, but they are not the same covered service.
| What | Verified status, August 2026 | What to check before booking |
|---|---|---|
| Medicare Part B diagnostic hearing and balance exams | Covered when a doctor or other health care provider orders the exam to determine whether medical treatment is needed | Whether the clinician accepts Medicare assignment and whether the facility adds a hospital outpatient copayment |
| Your Original Medicare share | After the Part B deductible, 20% of the Medicare-approved amount; other costs can apply | The Medicare-approved amount and any facility fee |
| Direct audiologist access under Medicare | One visit every 12 months without an order, but only for non-acute hearing conditions or diagnostic services related to surgically implanted hearing devices | Whether your reason for the visit fits the rule |
| Hearing aids and fitting exams under Original Medicare | Not covered | Full cash price, trial period, return fee, warranty, follow-up visits, and whether the quote is per ear or per pair |
| Medicare Advantage | Some plans offer hearing benefits beyond Original Medicare; details vary by plan | Network, allowance, copay, device list, fitting fees, prior authorization, and benefit frequency |
| Commercial insurance | No universal answer | Diagnostic-test coverage, referral requirement, network, hearing-aid benefit, and written preauthorization |
| OTC hearing aids | FDA-regulated category for adults 18+ with perceived mild-to-moderate hearing loss; available without a prescription | Device eligibility, return window, warranty, support, and final checkout price |
Primary-source verification: Medicare hearing and balance exams, Medicare hearing-aid coverage, and the FDA's OTC hearing-aid guide.
We do not publish generic national price ranges here because they create false precision. A useful quote has to name what is included. Before you agree to a cash-pay evaluation, ask:
- What is the total cash price for the diagnostic evaluation I need?
- Does that include speech testing, speech-in-noise testing if indicated, and tympanometry if indicated?
- Will I receive a copy of the audiogram and speech scores?
- Is any part of the appointment a separate hearing-aid evaluation or fitting charge?
- If devices are recommended, what is the all-in price, return period, restocking fee, warranty, and follow-up policy?
Get the answers in writing. That is not cynicism. It is the only way to compare quotes that may otherwise describe different services with the same friendly word: test.
Do I need hearing aids, and can I buy them over the counter?
You may not need hearing aids, and you should not choose a device category before you know the pattern. U.S. adults 18 and older with perceived mild-to-moderate loss can buy FDA-regulated OTC hearing aids without an exam or prescription. Severe, sudden, fluctuating, painful, draining, markedly one-sided, or vertigo-associated symptoms need professional assessment.
The OTC category took effect on October 17, 2022. OTC devices are air-conduction hearing aids for adults who perceive mild-to-moderate loss; they can be purchased in stores or online without an ENT visit, prescription, or audiologist fitting. Prescription devices remain available through licensed hearing-health professionals and can be appropriate across a wider range of losses. (FDA OTC hearing-aid guide)
In September 2024, the FDA authorized the first OTC hearing-aid software device: Apple's Hearing Aid Feature for AirPods Pro 2. The authorization was supported by a 118-person study in which self-fitting produced similar perceived benefit to professional fitting of the same device, with comparable in-ear amplification and speech-in-noise performance. (FDA authorization)
Apple's current specifications list the Hearing Aid Feature on AirPods Pro 2 and AirPods Pro 3 with compatible software and hardware. Availability and regulatory authorization vary by region. The feature is intended for adults 18+ with perceived mild-to-moderate hearing loss. (Apple feature availability)
We are not affiliated with Apple, and this is not a recommendation. It is a dated regulatory fact that changed what counts as a hearing aid — not proof that earbuds are the right solution for your ears.
See a doctor, preferably an ENT, before relying on an OTC device when the FDA red flags apply, including:
- Hearing that changed suddenly or fluctuates
- A clear one-sided difference or one-sided tinnitus
- Ear pain, drainage, blood, or deformity
- Significant dizziness or vertigo
- Hearing so poor that loud sounds or speech in a quiet room are difficult
- A device that does not provide enough benefit
The two-week Listening Situations Log
A vague memory is easy to dismiss. A dated pattern is not. Save or print this table, rate each situation twice over two weeks, and bring it with your medication timeline.
Rating: 0 = no difficulty · 1 = noticed effort · 2 = missed parts or asked for repeats · 3 = stopped following or avoided the situation
| Situation | Week 1 rating | Week 2 rating | One ear different? | What changed when you moved closer, reduced noise, or used captions? |
|---|---|---|---|---|
| One-to-one conversation in a quiet room | ||||
| Restaurant, café, or group meal | ||||
| Video meeting or speakerphone | ||||
| Conversation in the car | ||||
| Television compared with other people's preferred volume | ||||
| Phone call with each ear tested separately |
Add three facts beneath the table: when you first noticed the change, whether it was sudden or gradual, and whether tinnitus, fullness, pain, drainage, dizziness, or headache appeared with it.
That turns “I think my hearing is worse” into a pattern a clinician can work with. No account. No email. No invented diagnosis.
Who should I book — an audiologist, an ENT, or my regular doctor?
Match the professional to the pattern. Gradual difficulty in both ears usually starts with a diagnostic audiology appointment. Sudden, one-sided, painful, draining, or vertigo-associated change needs a physician or ENT first — same day when sudden. Menopause and HRT questions belong with the prescriber and should not delay the ear evaluation.
| Your situation | Who to see first | How fast |
|---|---|---|
| Sudden hearing drop in one or both ears | Urgent medical assessment or ENT | Today |
| Hearing change plus facial weakness, trouble speaking, new numbness, or severe sudden headache | Emergency services | Now |
| One-sided or clearly uneven loss that was not sudden | Physician or ENT, with audiometry | Promptly |
| Ear pain, drainage, blood, fever, or injury | Physician | Promptly |
| Vertigo episodes with hearing change, tinnitus, or fullness | Physician or ENT | Promptly |
| Gradual, roughly even difficulty that is worst in noise | Audiologist | Routine — but book it |
| Blocked feeling that may be wax | Physician or qualified hearing professional who can examine the ear | Routine unless sudden or one-sided |
| Started HRT and are worried about hearing | Hearing evaluation plus your HRT prescriber | Two appointments, two purposes; do not stop meanwhile |
That last row is the one that gets tangled most often. Your hearing evaluation and your HRT review are separate decisions with separate purposes. Do not let one hold up the other, and do not let an ear symptom become an unsupervised hormone change.
If your menopause care isn't covering this
Plenty of women reading this are dealing with something more basic: nobody is treating their menopause properly in the first place. Hearing came up, and it landed on a pile of symptoms nobody has taken seriously.
If that is you, Midi Health offers video visits focused on perimenopause and menopause. Midi is not an audiology or ENT service and cannot replace the hearing evaluation. The relevant reason to consider it is separate: a Midi clinician can review menopause symptoms, your current hormone regimen, and whether osteoporosis screening should be discussed under age- and risk-based guidance.
The honest limitations, so you do not waste a visit:
- Midi states that it is available in all 50 states.
- Self-pay pricing was $250 for an initial visit and $150 for continued-care visits, verified on Midi's pricing page in August 2026.
- Midi says it is in-network with most PPO plans, but benefits, copays, deductibles, and coinsurance vary by plan.
- Midi is not enrolled with Medicare or Medicare-related plans. Medicare beneficiaries can self-pay but cannot submit Midi-related claims.
- Midi says it cannot treat Medicaid or Medi-Cal patients, even as self-pay patients.
- Midi's main menopause page describes its hormonal prescriptions as FDA-approved. Midi also separately offers compounded Custom Rx products. Compounded preparations are not FDA-approved and are not equivalent to FDA-approved products. Confirm the exact product before filling it if FDA-approved-only care is your priority.
Sources: Midi menopause care, Midi pricing and insurance, Midi Custom Rx, and the FDA on compounded drugs.
Midi publishes a patient comment from Jessica M. saying she “felt heard and validated.” That is one person's description of the service, published by Midi itself — not independent review evidence, not a medical outcome claim, and not a promise of your experience.
Check Midi's current coverage and self-pay terms in your state →
Sponsored link — we may earn a commission. Our affiliate disclosure.
Not the right fit? If you use Medicaid or Medi-Cal, start with your plan's directory. If the ear problem is the decision in front of you, book audiology or medical care rather than an HRT platform. If you want to compare menopause-care models after that, use our online HRT provider guide.
What should I do about a hearing change this week?
Three actions, in order, none of which require proving menopause caused the change. Book the appropriate hearing evaluation. Build a dated medication-and-symptom timeline. Check whether osteoporosis screening has been addressed according to your age and fracture risk. The point is evidence, not another round of guessing.
Day 1 — Book the right test. If the change was sudden, seek medical care today. If it was gradual, ask for a diagnostic audiologic evaluation and name the real complaint: understanding speech in background noise. Ask whether speech-in-noise testing is available.
Day 1 — Start the two-week log. Use the six listening situations above. Rate the same situations twice so you can tell a persistent pattern from one bad room or one exhausted day.
Day 2 — Build your medication timeline. Include every prescription, over-the-counter medicine, and supplement: product, dose, start date, and any recent change. Include HRT by exact product, route, dose, and start date. Do not stop anything to “test” a theory.
Day 3 — Write down your ear history. Loud work, power tools, firearms, concerts, headphones, infections, injuries, family hearing history, tinnitus, fullness, drainage, pain, and vertigo. Note which ear and whether the beginning was sudden or gradual.
Day 4 — Gather the health facts you already have. Most recent blood pressure and glucose or A1c, if measured. Prior audiograms. Whether osteoporosis screening has been discussed and any fracture history. You are building context, not diagnosing yourself.
At the hearing appointment — ask these five:
- What do my thresholds look like in each ear across the full frequencies tested?
- Can we test speech in noise because that is where I struggle?
- Are my two ears different enough to need medical follow-up?
- Is there anything in my dated medication timeline that belongs with the prescriber?
- Can I have a copy of the audiogram and all speech scores?
If you use HRT, add these two for the prescriber — in a separate conversation:
- Does my current treatment still make sense for the menopause symptom or indication it was prescribed to treat?
- Based on my age and fracture-risk history, should osteoporosis screening be addressed?
Notice what is not on either list: “Should I stop my HRT because of my ears?” That is not a safe experiment. Do not let it become one.
How did The HRT Index verify this page?
This page was checked against primary research, federal coverage pages, FDA materials, and current provider pages in August 2026. We separated measured hearing from self-report and diagnosis codes, and provider-stated facts from independent regulatory facts. Nothing below is presented as clinician review; this remains editorial research.
The process follows The HRT Index Verification Standard, which reviews online menopause care through five pillars in this order: clinical legitimacy, care quality, medication fit, price transparency, access. For a symptom page, that means medical claims trace to primary or authoritative sources, commercial claims are dated, FDA-approved and compounded products stay separate, and unresolved facts are removed rather than filled with estimates.
Evidence read in full or checked directly
- Curhan et al. 2017, including the duration, formulation, and transdermal results
- Hsu et al. 2026, including the regression tables
- Curhan et al. 2021, including the bone-density, fracture, and bisphosphonate findings
- The AAO-HNS sudden-hearing-loss guideline and NIDCD sudden-deafness guidance
- The 2022 Menopause Society hormone-therapy position statement
- Medicare.gov's current pages for diagnostic hearing and balance exams and hearing aids
- FDA materials on approved menopausal hormone-therapy uses, OTC hearing aids, Apple's hearing-aid software authorization, compounded drugs, and testosterone
- The 2024 Lancet Commission and the ACHIEVE randomized trial
Evidence verified from the published abstract or institutional record
- Fu et al. 2025: cohort size, follow-up, diagnosis events, hazard ratios, MHT subgroup finding, and mediation estimates
- Jang et al. 2025: 4,448 participants, study window, trajectory split, and metabolic associations
- Svedbrant 2015 and the early mechanistic or cohort studies where the complete article was not openly accessible
That distinction matters. We do not describe an abstract check as a full-text review.
Provider-stated versus independently verified commercial facts
| Claim used on this page | Source type | Status, August 2026 | What the reader should do |
|---|---|---|---|
| Find My HRT Path says no email or account is required, nothing is sold or stored, and health answers remain on the page | Site-stated on the live tool | Current when checked; not independently audited at the code or network level | Review the consumer health data/privacy policy before entering sensitive information |
| Midi available in all 50 states | Provider-stated on Midi's menopause page | Current when checked; not independently re-tested state by state | Confirm availability during booking |
| Midi self-pay: $250 initial, $150 continued-care visit | Provider-stated on Midi's pricing page | Current when checked | Confirm before submitting payment |
| Midi PPO, Medicare, Medicaid, and Medi-Cal terms | Provider-stated on Midi's pricing page | Current when checked | Verify with the plan and Midi for your exact coverage |
| Midi main menopause prescriptions described as FDA-approved; Custom Rx separately includes compounded products | Provider-stated product descriptions; FDA status of compounding checked independently | Categories kept separate in this article | Confirm the exact prescription and dispensing source before filling |
| Apple Hearing Aid Feature compatibility | Current manufacturer-stated hardware/software requirements; FDA authorization checked independently | AirPods Pro 2 and AirPods Pro 3 listed by Apple | Check current compatibility and region availability |
| Medicare diagnostic coverage and hearing-aid exclusion | Federal primary source | Current Medicare.gov language | Confirm provider, facility, and plan-specific cost before the visit |
Claims we did not publish
We did not publish a national cash-price range for diagnostic tests or hearing aids, a state-mandate count, or a prevalence claim specific to perimenopausal women because we could not support a single current number that would be accurate for the reader in front of us.
Find My HRT Path is used only for HRT routing on this page. Its live function does not diagnose hearing loss or replace audiology.
What this page is: editorial research by The HRT Index. It is educational, not medical advice, and it has not been reviewed by a clinician. See our medical review policy and corrections page.
Recheck schedule: Midi pricing, coverage language, destinations, and disclosures monthly; the evidence matrix and commercial ledger quarterly; Medicare each January and after a CMS change; FDA status, safety guidance, and major clinical guidelines when an update is issued.
Frequently asked questions
The follow-up questions all come back to three distinctions: sudden versus gradual, one ear versus both, and hearing care versus hormone care. Menopause can share the timeline without proving the cause. The answers below close the common gaps without turning a research association into a treatment instruction.
Can perimenopause cause hearing loss before my periods stop? Hearing can change during perimenopause, but perimenopause has not been established as a direct cause. The Korean trajectory study found two group-level patterns around the final menstrual period; it cannot tell one woman that her symptom is hormonal. Get the change assessed regardless of cycle stage.
Can menopause cause hearing loss in one ear? Menopause has not been established as a cause of one-sided hearing loss. A clear new difference between ears — especially a sudden one — deserves medical evaluation rather than a hormone explanation.
Is hearing loss from menopause permanent? Permanence depends on the type. Wax, fluid, and some middle-ear problems can improve; gradual sensorineural damage usually does not reverse. Sudden sensorineural loss can recover partly or fully in some people, but it needs urgent assessment because treatment is time-sensitive.
Will HRT reverse my hearing loss? No human evidence establishes HRT as a treatment that reverses hearing loss, and no FDA-approved menopausal hormone therapy is indicated for hearing. HRT decisions should be based on an appropriate menopause indication and clinician assessment, not an ear symptom.
Should I stop my HRT because of what I read here? No. Do not change a prescribed medication because of a webpage. Symptoms being treated by HRT may return after stopping, and stopping offers no proven hearing benefit; take the concern to the prescriber and evaluate the ears separately.
Is a patch safer than tablets for my hearing? No route has been proven safer for hearing. In the Curhan study, transdermal associations were described as similar to oral associations, although patch use was less common. That is not evidence to switch routes for an ear symptom.
Is progesterone worse for hearing than estrogen? The larger prospective dataset did not support a simple “progestogen harms, estrogen protects” story. Do not remove prescribed endometrial protection because of hearing headlines: for a woman with a uterus using systemic estrogen, adequate progestogen is generally recommended. Recommended low-dose vaginal estrogen is a separate category and generally does not require a progestogen.
Why is hearing so much worse in restaurants than at home? Background noise and competing voices remove cues your brain uses in quiet. A person can detect tones or follow one voice at home yet struggle when speech must be separated from noise. Ask whether speech-in-noise testing fits that complaint.
Can low estrogen cause a blocked or full feeling in my ears? Low estrogen has not been established as the cause of ear fullness. Wax, middle-ear pressure or fluid, Ménière's disease, and sudden sensorineural loss can all involve fullness. Persistent, one-sided, fluctuating, or sudden fullness deserves assessment.
At what age does hearing loss usually start in women? There is no single starting age. Change accumulates differently with age, genetics, noise exposure, illness, and medication history. A baseline becomes useful when you notice difficulty — not when you reach a particular birthday.
Does hearing loss cause dementia? Hearing loss is associated with dementia risk and appears in the 2024 Lancet Commission's risk model, but association is not proof of direct causation. ACHIEVE was negative overall; its cognitive benefit appeared in an older, higher-risk subgroup, not the full sample and not a midlife-menopause population.
Is a free online hearing test good enough? An online or app-based test can be a useful screening prompt. It cannot inspect the ear canal, assess the middle ear, reproduce every clinical speech test, or replace urgent medical evaluation for sudden or one-sided change. A concerning result — or persistent real-world difficulty despite a normal result — deserves a diagnostic evaluation.
Do I need an ENT or an audiologist? Gradual, roughly equal difficulty generally starts with an audiologist. Sudden, one-sided, painful, draining, injured, or vertigo-associated change should start with a physician or ENT. Neurological symptoms need emergency care.
Could a medicine be causing this? It is possible for some medicines to affect hearing or balance, but the answer depends on the exact drug, dose, treatment context, and timing. Do not stop it yourself. Bring a dated list to the prescriber or pharmacist and pair that review with hearing testing.
I had a hysterectomy. Does that change the answer? A hysterectomy removes the uterus; it does not always remove the ovaries or create surgical menopause. Record whether one or both ovaries were removed and at what age. The hearing studies on surgical menopause cannot be applied to “hysterectomy” without that distinction.
Does testosterone or another hormone help hearing in women? There is no good evidence supporting testosterone as a hearing treatment, and no testosterone product is FDA-approved specifically for women in the United States or for hearing loss. Testosterone is a Schedule III controlled substance in the United States and requires a prescription; it should never be presented as a casual hearing intervention.
Is tinnitus the same thing as hearing loss? No. Tinnitus is the perception of sound without an external source; hearing loss is reduced ability to detect or understand sound. They often occur together and can share causes, but the evidence and next steps differ. See menopause and tinnitus.
The bottom line
Your hearing may be changing, and the work it takes to follow dinner-table conversation is real. Menopause shares the timeline, but it has not been established as the independent cause of every midlife hearing change. HRT is not the hearing treatment. The useful next move is to identify the pattern and measure it.
Book the right test. Bring the log. Ask about each ear, the higher frequencies, and speech in noise. Keep the results.
If the change was sudden, stop reading and get medical care today.
And if menopause care itself is what has been neglected — if hearing was just the symptom that finally made you look — fix that on its own terms, with the ear decision kept separate.
Still not sure which online menopause-care model fits your symptoms, medication preferences, insurance, state, and safety history? Use the free matching tool.
The HRT Index publishes independent educational research, not medical advice, and this page has not been reviewed by a clinician. FDA-approved and compounded options are labeled distinctly; compounded preparations are never presented as equivalent to FDA-approved medication. Some links are sponsored, and we may earn a commission. See our affiliate disclosure.